Innovations in Hearing Accessibility and Technology (IHAT) Study for Hearing Loss
This study is looking at different ways to help people with mild to moderate hearing loss using hearing aids. Researchers want to compare traditional prescription hearing aids, fitted by a hearing specialist, with several types of over-the-counter (OTC) hearing aids. These OTC options include those fitted by a specialist, fitted remotely, or self-fitted without professional help. The study will look at how each type affects your hearing, daily experiences, thinking skills, and brain activity. They also want to understand who prefers each option, what helps or hinders these choices, and the costs involved. You can join if you are 40 or older, have mild to moderate hearing loss in both ears, and haven't used hearing aids for more than 3 months. The study aims to enroll 280 participants, but its current status is unclear.
- Study design
- This study is a randomized controlled trial with four groups. It plans to enroll 280 participants to compare different hearing aid fitting methods.
- What's involved
- You would be randomized to one of four groups and have your hearing aid benefit measured at the start, after 6 months, and after 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after receiving their intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Innovations in Hearing Accessibility and Technology (IHAT) Study
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Vinaya Manchaiah, AuD, MBA, PhD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
- Anu Sharma, PhD · PRINCIPAL_INVESTIGATOR · University of Colorado, Boulder
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Abbreviated Profile of Hearing Aid Benefit (APHAB)T0 = Baseline, T1 = 6 months post intervention, T2 = 12 months post intervention
It is a 24-item self-reported measure of hearing disability and hearing aid benefit. It includes four subscales that address different listening challenges: ease of communication, reverberation, background noise, and aversiveness of sounds, with each subscales comprising six items. The ease of communication, reverberation, and background noise primarily measure challenges related to speech communication. The global score on the APHAB is the average of these three subscale scores. The hearing aid benefit is calculated by comparing the difficulty level reported without amplification (unaided) to the difficulty level with amplification (aided). Scores range from 1% to 99%, with higher scores indicating greater perceived hearing difficulty.